Editas Medicine, Inc. (EDIT)

Editas Medicine Revenue

Editas Medicine had revenue of $69.41M in the twelve months ending March 31, 2024, with 204.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.14M, a -88.48% decrease year-over-year. In the year 2023, Editas Medicine had annual revenue of $78.12M with 296.32% growth.

• Revenue (ttm): $69.41M
• Revenue Growth: +204.54%
• P/S Ratio: 5.38
• Revenue / Employee: $261,913
• Employees: 265
• Market Cap: 373.36M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	78.12M	58.41M	296.32%
Dec 31, 2022	19.71M	-5.83M	-22.83%
Dec 31, 2021	25.54M	-65.19M	-71.85%
Dec 31, 2020	90.73M	70.20M	341.93%
Dec 31, 2019	20.53M	-11.41M	-35.71%
Dec 31, 2018	31.94M	18.21M	132.64%
Dec 31, 2017	13.73M	7.68M	126.80%
Dec 31, 2016	6.05M	4.42M	271.58%
Dec 31, 2015	1.63M	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.